Study Title
Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression in Patients with Metastatic Non-Small-Cell Lung Cancer - A Randomized Phase 3 Trial
Study Number
CCTG-BR38
Enrollment status
Open
Categories
2nd Line Metastatic, Stage 4 Patients with Progressive Disease, Lung Cancer, Non-Small Cell Lung Cancer
Study Summary
This study is being done to answer the following question: Can the chance of lung cancer growing or spreading be lowered by adding targeted radiotherapy to the usual combination of drugs?
This study is being done to find out if this approach is better or worse than the usual approach for lung cancer. The usual approach is defined as the care most people get for non-small cell lung cancer.
This study is being done to find out if this approach is better or worse than the usual approach for lung cancer. The usual approach is defined as the care most people get for non-small cell lung cancer.
Study Coordinator(s)
- Angie, 309-243-3613, aearles@illinoiscancercare.com
- Heather, 309-243-3661 hthulean@illinoiscancercare.com
- Hannah, 309-243-3628 hknight@illinoiscancercare.com
Study Link
View Study DetailsAdditional Information
Credentialed OSF Glen Oak